Soltis Investment Advisors »

Lexeo Therapeutics shares owned by Soltis Investment Advisors

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Soltis Investment Advisors from 13F filings

Historical chart of Soltis Investment Advisors investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Soltis Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Soltis Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $133k 20k 6.64
2025-06-30 $80k 20k 4.02
2025-03-31 $69k 20k 3.47

More positions owned by Soltis Investment Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Security Natl Finl Corp Cl A New (SNFCA)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom (AVGO)
Schwab Strategic Tr Intl Eqty Etf (SCHF)

View all positions for Soltis Investment Advisors

Top funds holding Lexeo Therapeutics

Henderson Group
Frazier Life Sciences Management
Balyasny Asset Management
Affinity Asset Advisors
Citadel Advisors
Vestal Point Capital
Woodline Partners
Millennium Management
Vanguard Group
BlackRock
Point72 Asset Management
ADAR1 Capital Management
Blackstone Group
D1 Capital Partners
683 Capital Management

View all funds holding Lexeo Therapeutics